These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25464398)

  • 61. Impact of Baseline Features and Risk Factor Control on Cognitive Function in the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial.
    Turan TN; Al Kasab S; Smock A; Cotsonis G; Bachman D; Lynn MJ; Nizam A; Derdeyn CP; Fiorella D; Janis S; Lane B; Montgomery J; Chimowitz MI;
    Cerebrovasc Dis; 2019; 47(1-2):24-31. PubMed ID: 30763948
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Angioplasty and stenting of extracranial brachiocephalic stenoses (other than the cervical carotid bifurcation) and intracranial stenoses.
    American Society for Interventional and Therapeutic Neuroradiology
    AJNR Am J Neuroradiol; 2001 Sep; 22(8 Suppl):S31-3. PubMed ID: 11686073
    [No Abstract]   [Full Text] [Related]  

  • 63. Long-term outcomes of a randomized clinical trial of stenting vs aggressive medical therapy for intracranial arterial stenosis.
    Starke RM; Komotar RJ; Connolly ES
    Neurosurgery; 2014 Oct; 75(4):N19-21. PubMed ID: 25232790
    [No Abstract]   [Full Text] [Related]  

  • 64. Letter by Desai et al regarding article, "Role of balloon-expandable stents in intracranial atherosclerotic disease in a series of 182 patients".
    Desai SK; Murph D; Von Ritschl R
    Stroke; 2013 Oct; 44(10):e131. PubMed ID: 24003045
    [No Abstract]   [Full Text] [Related]  

  • 65. Angioplasty and stenting for intracranial stenosis.
    Izumi T; Imamura H; Sakai N; Miyachi S
    Neurol Med Chir (Tokyo); 2014; 54(1):46-53. PubMed ID: 24390191
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment.
    Holmstedt CA; Turan TN; Chimowitz MI
    Lancet Neurol; 2013 Nov; 12(11):1106-14. PubMed ID: 24135208
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intra- and extracranial atherosclerotic stenosis in China: epidemiology, diagnosis, treatment and risk factors.
    Liu CY; Chen CQ
    Eur Rev Med Pharmacol Sci; 2014 Nov; 18(22):3368-79. PubMed ID: 25491610
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Angioplasty and Stenting for Intracranial Stenosis.
    Izumi T; Imamura H; Sakai N; Miyachi S
    Neurol Med Chir (Tokyo); 2014; 54 Suppl 2():46-53. PubMed ID: 26236816
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diabetes mellitus does not increase the risk of adverse long-term outcomes after intracranial stent placement.
    Li BH; Yin YW; Gao CY; Hu ZC; Wang JH; Zhang LL; Li JC
    Cell Biochem Biophys; 2015 Jan; 71(1):413-8. PubMed ID: 25182003
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Stenting in Intracranial Stenosis: Current Controversies and Future Directions.
    Chatterjee AR; Derdeyn CP
    Curr Atheroscler Rep; 2015 Aug; 17(8):48. PubMed ID: 26104430
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Intracranial artery stenosis: does stenting provide advantages?--Stenting does not reduce the risk of stroke in patients with intracranial stenosis].
    Weimar C
    Dtsch Med Wochenschr; 2014 Mar; 139(11):524. PubMed ID: 24595709
    [No Abstract]   [Full Text] [Related]  

  • 72. Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial.
    Turan TN; Lynn MJ; Nizam A; Lane B; Egan BM; Le NA; Lopes-Virella MF; Hermayer KL; Benavente O; White CL; Brown WV; Caskey MF; Steiner MR; Vilardo N; Stufflebean A; Derdeyn CP; Fiorella D; Janis S; Chimowitz MI;
    Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):e51-60. PubMed ID: 22991350
    [No Abstract]   [Full Text] [Related]  

  • 73. Outcomes after stenting for symptomatic intracranial arterial stenosis: a systematic review and meta-analysis.
    Wang T; Yang K; Luo J; Gao P; Ma Y; Wang Y; Li L; Liu Y; Feng Y; Wang X; Jiao L
    J Neurol; 2020 Mar; 267(3):581-590. PubMed ID: 30612142
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Medical and Endovascular Treatments for Intracranial Atherosclerotic Stenosis: A Network Meta-Analysis.
    Peng G; Li K; Wang A; Tian X; Qi Z; Li S; Tong X; Deng Y; Sun X; Miao Z
    Transl Stroke Res; 2023 Feb; 14(1):83-93. PubMed ID: 34792778
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Stenting Plus Medical Therapy and Risk of Stroke and Death in Patients With Symptomatic Intracranial Stenosis.
    Zedde M; Pascarella R
    JAMA; 2022 Dec; 328(24):2455-2456. PubMed ID: 36573985
    [No Abstract]   [Full Text] [Related]  

  • 76. Stenting Plus Medical Therapy and Risk of Stroke and Death in Patients With Symptomatic Intracranial Stenosis.
    Alexander MJ; Yu W;
    JAMA; 2022 Dec; 328(24):2456-2457. PubMed ID: 36573984
    [No Abstract]   [Full Text] [Related]  

  • 77. A Case of Bilateral Middle Cerebral Artery Stenosis with Unilateral M1 Stenting.
    Alam F; Rana S; Hasan MM; Islam MM; Hossain MI; Islam MS
    Mymensingh Med J; 2022 Oct; 31(4):1197-1201. PubMed ID: 36189572
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Symptomatic intracranial atherosclerotic disease: what is the best treatment option?
    Gupta R
    Stroke; 2008 Jun; 39(6):1661-2. PubMed ID: 18420949
    [No Abstract]   [Full Text] [Related]  

  • 79. Emerging endovascular therapies for symptomatic intracranial atherosclerotic disease.
    Fiorella D; Woo HH
    Stroke; 2007 Aug; 38(8):2391-6. PubMed ID: 17585085
    [No Abstract]   [Full Text] [Related]  

  • 80. Stenting Plus Medical Therapy and Risk of Stroke and Death in Patients With Symptomatic Intracranial Stenosis-Reply.
    Gao P; Wang T; Jiao L
    JAMA; 2022 Dec; 328(24):2457. PubMed ID: 36573982
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.